Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Bristol-Myers Squibb (BMS) building

BMS’ Yervoy fails prostate cancer trial

Unable to improve overall survival in phase III

- PMLiVE

FDA panel backs Perjeta in early breast cancer

Unanimous recommendation for use alongside Herceptin

- PMLiVE

Former Bausch + Lomb CEO to lead Forest Labs

Brenton Saunders succeeds Howard Solomon who steps down after 36 years

EU flag

Euro Parliament backs biopiracy protocol

Aims to protect IP of traditional medicine knowledge used by indigenous communities

New finance head for Xenon

Ian Mortimer joins from Tekmira

- PMLiVE

In guts we trust

The new social currency within the sharing economy is trust

- PMLiVE

Boehringer creates ‘Captain Zantac’

Animated fireman fronts marketing campaign in US for heartburn remedy

- PMLiVE

Eisai lines-up Fycompa access programme for Germany

But sales suspension for epilepsy drug will continue

- PMLiVE

Gedeon Richter falls foul of ABPI

Hungarian pharma company found to have breached Code of Practice

- PMLiVE

UK to improve commercial viability of antibiotic research

Government unveils new research incentives as part of antimicrobial resistance strategy

Bristol-Myers Squibb (BMS) building

BMS says it defends Sprycel patent in India

Blocks attempts to issue compulsory license for leukaemia drug

- PMLiVE

Baxter’s Nick Roger joins Bedrock

Takes up role as strategic solutions director at med comms agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links